Nifty
:
11504.95
Sensex
:
38775.35
230.75 (2.05%)
760.73 (2.00%)
Nifty
Sensex
:
:
11504.95
38775.35
230.75 (2.05%)
760.73 (2.00%)

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :
76/99

BSE: 500660 | NSE: GLAXO

NSE BSE
1384.20
20-Sep-2019
  • Open
  • High
  • Low
  • Previous Close
  •  1381.00
  •  1423.00
  •  1366.80
  •  1395.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  141731
  •  1979.68
  •  1624.55
  •  1130.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 23,466.97
  • 52.12
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 22,296.21
  • 1.44%
  • 10.40

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 0.56%
  • 10.82%
  • FII
  • DII
  • Others
  • 8.13%
  • 3.00%
  • 2.49%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -1.33
  • 2.53

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 1.29
  • 7.63

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -2.04
  • 8.09

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 56.35
  • 67.05
  • 63.36

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.00
  • 12.26
  • 11.15

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.92
  • 38.84
  • 37.50

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
787.97
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
622.68
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
165.29
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
20.98%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
30.81
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.93
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
19.06
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
176.11
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
62.57
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
113.54
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
14.41%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
6.70
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Net Sales
-
3,128.12
2,871.45
2,908.47
2,837.91
3,362.91
2,607.70
2,692.06
2,455.38
2,151.06
1,907.77
Net Sales Growth
-
8.94%
-1.27%
2.49%
-15.61%
28.96%
-3.13%
9.64%
14.15%
12.75%
 
Cost Of Goods Sold
-
1,358.03
1,241.31
1,397.75
1,324.90
1,327.66
1,171.68
1,100.57
923.50
785.73
700.01
Gross Profit
-
1,770.09
1,630.14
1,510.72
1,513.02
2,035.25
1,436.02
1,591.49
1,531.87
1,365.33
1,207.75
GP Margin
-
56.59%
56.77%
51.94%
53.31%
60.52%
55.07%
59.12%
62.39%
63.47%
63.31%
Total Expenditure
-
2,527.32
2,365.66
2,489.49
2,359.64
2,788.33
2,124.49
1,915.22
1,693.90
1,478.25
1,324.67
Power & Fuel Cost
-
27.94
26.44
27.82
25.97
31.17
23.85
22.50
26.70
26.75
24.66
% Of Sales
-
0.89%
0.92%
0.96%
0.92%
0.93%
0.91%
0.84%
1.09%
1.24%
1.29%
Employee Cost
-
537.20
523.40
483.01
443.37
493.02
362.05
295.52
278.36
234.53
203.97
% Of Sales
-
17.17%
18.23%
16.61%
15.62%
14.66%
13.88%
10.98%
11.34%
10.90%
10.69%
Manufacturing Exp.
-
115.55
110.55
108.26
118.09
367.24
127.78
113.62
111.44
67.51
60.08
% Of Sales
-
3.69%
3.85%
3.72%
4.16%
10.92%
4.90%
4.22%
4.54%
3.14%
3.15%
General & Admin Exp.
-
178.60
203.53
195.08
154.85
178.21
135.34
126.10
108.51
145.09
130.13
% Of Sales
-
5.71%
7.09%
6.71%
5.46%
5.30%
5.19%
4.68%
4.42%
6.75%
6.82%
Selling & Distn. Exp.
-
202.81
154.38
178.91
164.47
222.31
186.23
160.74
157.60
140.85
131.33
% Of Sales
-
6.48%
5.38%
6.15%
5.80%
6.61%
7.14%
5.97%
6.42%
6.55%
6.88%
Miscellaneous Exp.
-
107.20
106.05
98.67
127.99
168.72
117.55
96.17
87.78
72.33
131.33
% Of Sales
-
3.43%
3.69%
3.39%
4.51%
5.02%
4.51%
3.57%
3.58%
3.36%
3.84%
EBITDA
-
600.80
505.79
418.98
478.27
574.58
483.21
776.84
761.48
672.81
583.10
EBITDA Margin
-
19.21%
17.61%
14.41%
16.85%
17.09%
18.53%
28.86%
31.01%
31.28%
30.56%
Other Income
-
102.32
54.54
73.07
123.18
258.80
222.30
223.90
186.59
217.06
194.80
Interest
-
0.55
0.19
0.25
0.42
0.47
0.33
0.33
0.33
0.62
0.37
Depreciation
-
48.59
37.99
26.35
24.95
25.35
19.88
17.84
20.41
17.63
16.37
PBT
-
653.97
522.17
465.46
576.08
807.56
685.30
982.58
927.33
871.62
761.16
Tax
-
237.28
189.24
174.37
202.25
279.27
229.78
272.48
176.20
293.35
260.70
Tax Rate
-
34.76%
35.05%
34.11%
34.97%
36.96%
32.30%
32.66%
29.13%
33.66%
34.25%
PAT
-
445.39
350.73
336.81
376.14
476.41
481.67
561.88
428.59
578.27
500.46
PAT before Minority Interest
-
445.39
350.73
336.81
376.14
476.41
481.67
561.88
428.59
578.27
500.46
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
14.24%
12.21%
11.58%
13.25%
14.17%
18.47%
20.87%
17.46%
26.88%
26.23%
PAT Growth
-
26.99%
4.13%
-10.46%
-21.05%
-1.09%
-14.28%
31.10%
-25.88%
15.55%
 
Unadjusted EPS
-
26.29
41.41
39.76
44.41
56.24
56.87
66.34
50.60
66.18
59.96

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Shareholder's Funds
2,139.83
2,057.33
2,006.86
2,183.25
1,828.98
1,989.73
2,006.83
1,935.70
1,951.58
1,786.09
Share Capital
169.41
84.70
84.70
84.70
84.70
84.70
84.70
84.70
84.70
84.70
Total Reserves
1,970.42
1,972.63
1,922.15
2,098.55
1,744.28
1,905.03
1,922.13
1,851.00
1,866.88
1,701.39
Non-Current Liabilities
2,860.37
2,632.47
3,699.70
3,498.32
197.04
158.59
158.45
172.78
-51.43
-39.47
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.18
0.58
0.99
1.60
2.63
3.61
4.14
4.59
5.16
5.42
Long Term Provisions
2,920.20
2,733.36
3,786.83
3,592.19
272.21
242.29
236.05
224.81
0.00
0.00
Current Liabilities
2,804.07
1,599.86
720.23
783.63
1,106.55
888.91
836.40
859.59
3,179.07
2,718.89
Trade Payables
405.81
505.86
278.93
327.74
308.04
285.63
237.37
200.58
334.36
294.42
Other Current Liabilities
802.71
842.35
390.47
202.82
130.09
84.13
86.82
67.25
12.60
22.78
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
1,595.54
251.66
50.83
253.08
668.42
519.15
512.21
591.77
2,832.12
2,401.69
Total Liabilities
7,804.27
6,289.66
6,426.79
6,465.20
3,132.57
3,037.23
3,001.68
2,968.07
5,079.22
4,465.51
Net Block
429.99
322.81
252.71
204.04
123.08
100.09
89.42
99.15
108.95
92.83
Gross Block
559.05
405.89
299.09
228.36
363.34
343.22
316.18
315.80
362.54
333.32
Accumulated Depreciation
129.06
83.08
46.38
24.32
240.26
243.13
226.76
216.65
253.59
240.49
Non Current Assets
4,445.06
4,103.26
4,752.54
4,087.05
545.58
413.30
355.01
363.01
235.57
262.64
Capital Work in Progress
1,002.64
922.90
605.46
267.67
115.22
61.86
43.79
16.19
8.72
21.36
Non Current Investment
1.69
1.84
5.40
6.04
0.06
0.06
10.06
54.98
117.90
148.46
Long Term Loans & Adv.
3,002.88
2,855.66
3,888.91
3,609.24
296.09
237.73
194.55
157.01
0.00
0.00
Other Non Current Assets
7.84
0.06
0.06
0.06
11.13
13.55
17.19
35.68
0.00
0.00
Current Assets
3,359.21
2,186.41
1,674.25
2,378.15
2,586.98
2,623.94
2,646.67
2,605.06
4,843.65
4,202.88
Current Investments
0.00
0.00
0.00
0.00
0.00
10.00
44.91
57.21
0.00
0.00
Inventories
486.49
500.18
425.80
525.87
375.58
346.97
285.15
333.44
285.55
257.30
Sundry Debtors
120.49
146.96
170.80
126.56
100.32
96.39
115.90
85.31
47.03
53.73
Cash & Bank
1,171.35
1,296.41
899.61
1,391.90
1,910.61
2,041.58
2,066.77
2,014.36
2,002.89
1,733.90
Other Current Assets
1,580.88
43.34
52.27
23.24
200.47
128.99
133.94
114.74
2,508.18
2,157.95
Short Term Loans & Adv.
1,468.58
199.52
125.77
310.58
112.04
71.19
58.18
50.12
2,454.34
2,127.55
Net Current Assets
555.14
586.54
954.01
1,594.52
1,480.43
1,735.03
1,810.27
1,745.46
1,664.58
1,483.98
Total Assets
7,804.27
6,289.67
6,426.79
6,465.20
3,132.56
3,037.24
3,001.68
2,968.07
5,079.22
4,465.52

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Cash From Operating Activity
399.38
472.80
234.37
138.90
337.64
281.31
313.59
335.37
479.36
511.51
PBT
653.97
522.17
465.46
576.08
807.56
685.30
982.58
927.33
871.62
761.16
Adjustment
-31.36
-12.17
-46.47
-96.01
-173.66
-156.37
-159.63
-139.38
-89.96
-69.78
Changes in Working Capital
-4.19
164.56
-26.69
-124.41
-36.90
11.45
56.35
-73.09
12.66
20.47
Cash after chg. in Working capital
618.41
674.55
392.29
355.67
597.00
540.37
879.30
714.86
794.32
711.85
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-204.34
-202.01
-160.59
-205.95
-252.43
-244.09
-318.38
-316.53
-313.89
-185.38
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-14.69
0.25
2.67
-10.82
-6.93
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-143.34
-104.19
300.64
499.02
180.01
188.98
-109.65
358.03
86.76
660.78
Net Fixed Assets
-232.90
-424.24
-408.52
-61.62
-73.47
-45.11
-27.98
39.27
-16.58
-18.44
Net Investments
23.26
3.56
0.64
-5.96
10.00
44.92
57.21
0.55
30.56
560.97
Others
66.30
316.49
708.52
566.60
243.48
189.17
-138.88
318.21
72.78
118.25
Cash from Financing Activity
-358.36
-306.63
-510.76
-638.33
-496.99
-494.14
-440.63
-394.81
-297.15
-394.84
Net Cash Inflow / Outflow
-102.33
61.97
24.24
-0.42
20.66
-23.85
-236.69
298.59
268.97
777.45
Opening Cash & Equivalents
201.10
139.13
114.89
115.30
94.93
137.67
374.36
75.77
1,734.03
956.58
Closing Cash & Equivalent
98.78
201.10
139.13
114.89
115.59
113.82
137.67
374.36
2,003.01
1,734.03

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Book Value (Rs.)
126.31
121.44
118.46
128.88
107.96
117.45
118.46
114.26
115.20
105.43
ROA
5.77%
5.52%
5.23%
7.84%
15.44%
15.95%
18.82%
10.65%
12.12%
11.74%
ROE
21.22%
17.26%
16.08%
18.75%
24.95%
24.10%
28.50%
22.05%
30.94%
29.77%
ROCE
32.54%
26.56%
24.39%
28.82%
39.53%
35.54%
42.24%
31.05%
46.54%
45.16%
Fixed Asset Turnover
6.48
8.21
11.38
9.59
9.82
8.13
8.74
7.40
6.31
5.91
Receivable days
15.60
20.03
18.09
14.59
10.35
14.45
13.29
9.62
8.38
10.45
Inventory Days
57.56
58.36
57.89
57.97
38.01
43.02
40.86
45.01
45.13
45.88
Payable days
73.24
66.11
51.51
53.81
43.72
49.18
47.40
62.14
88.58
85.41
Cash Conversion Cycle
-0.07
12.28
24.47
18.75
4.64
8.28
6.75
-7.51
-35.07
-29.09
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
1232.59
2856.45
2045.74
1373.88
1612.26
2146.51
2497.59
1848.25
1403.44
2037.83

Annual Reports:

FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011
FY 2010

News Update:


  • GlaxoSmithkline Pharmaceuticals divests land in Mumbai
    31st Aug 2019, 09:22 AM

    The company has paid a sum of Rs 337.46 crore towards obtaining all required statutory and regulatory approvals

    Read More
  • Glaxosmithkline Pharmaceuticals reports 35% rise in Q1 consolidated net profit
    22nd Jul 2019, 15:22 PM

    Total consolidated income of the company increased by 8.64% at Rs 818.78 crore for Q1FY20

    Read More
  • Glaxosmithkline Phar - Quarterly Results
    22nd Jul 2019, 14:40 PM

    Read More
  • Glaxosmithkline Pharmaceuticals to focus on 20 brands, 5 therapeutic segments: Report
    16th Jul 2019, 11:30 AM

    The drug maker is also looking for deeper engagement with distribution channel partners and securing control over the supply chain with its own factories

    Read More
  • Glaxosmithkline Pharmaceuticals optimising product portfolio, focusing on key brands
    24th Jun 2019, 12:21 PM

    The company is also looking to launch some new products in the country over the next 15 months

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.